πŸ‡ΊπŸ‡Έ FDA
Patent

US 8461339

Pharmaceutical compounds

granted A61PA61P35/00

Quick answer

US patent 8461339 (Pharmaceutical compounds) held by SENTINEL ONCOLOGY LIMITED expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SENTINEL ONCOLOGY LIMITED
Grant date
Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P35/00